NOVEL THERAPEUTICAL USE OF BYAKANGELICIN

Details for Australian Patent Application No. 2003219580 (hide)

Owner BIOSYNERGEN, INC.

Inventors SONG, Dong-Keun; SON, Jong-Keun

Pub. Number AU-A-2003219580

PCT Number PCT/KR03/00682

PCT Pub. Number WO2003/084530

Priority 10-2002-0018542 04.04.02 KR

Filing date 4 April 2003

Wipo publication date 20 October 2003

International Classifications

A61K 031/37

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10-2002-0018542 04.04.02 KR

27 November 2003 Application Open to Public Inspection

  Published as AU-A-2003219580

23 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219581-Process for preparing acid salts of gemifloxacin

2003219579-NOVEL THERAPEUTICAL USE OF ERYTHRO-1 (4'-METHOXYPHENYL)1,2-PROPANE DIOL